March 9, 2023 11:55 AM EST
Pharma
FDA+
Manufacturing

Apo­tex is­sues re­call of eye treat­ment over cracked bot­tle caps

Tyler Patchen

News Reporter

Gener­ics man­u­fac­tur­er Apo­tex is vol­un­tar­i­ly pulling six lots of its bri­moni­dine tar­trate oph­thalmic so­lu­tion off the shelves af­ter cracks were re­port­ed on some bot­tle caps …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times